Claudio D´Ambrosio named Chief Commercial Officer, US at Noona Healthcare

Noona Healthcare has appointed Claudio D´Ambrosio, PhD, to the position of Chief Commercial Officer, US as of 22.1.2018. He will join Noona´s management team being responsible for commercial strategy and partnerships in the US.

“I am thrilled to join Noona and to be part of their mission. What impressed me from the first minute is how Noona is designed and built based on deep empathy – for patients and their caregivers. It is an amazing technology, truly unique in its kind”, Claudio says.

Claudio D’Ambrosio, PhD, has extensive expertise in the healthcare sector, particularly in the field of Oncology where he laid the first solid foundations as cancer research scientist from the highly prestigious London Research Institute (‘Crick Institute’). Living and breathing at the convergence of science and business strategy, he launched and rapidly expanded Oncology Strategy Consulting practice, initially based in Europe, to then build and lead professional service enterprise Deallus Consulting in the United States. Claudio D’Ambrosio was consequently appointed CEO and joined the Board of Directors of the global organization with operations in Americas, Europe and Japan/East Asia. Over the past years, before joining forces with Noona Healthcare, Claudio D’Ambrosio put to use his entrepreneurial know-how as strategic advisor to multiple technology and professional service startups, both in Europe and the US.

“The healthcare sector itself has incubated a disease: a lack of patient-level data fluidity. We still live in a highly atomized world when it comes to patient reported outcomes data. Millions of cancer patients are treated each day with increasingly complex cocktails of therapies. At the same time critical real-world information is not available: it isn’t generated; isn’t fluid; isn’t shared and used; to the advantage of the patient, the payer and the drug manufacturer. Noona gives the field of real-world evidence and patient centricity a good name. And a good push”, Claudio says.

“Claudio is a world-class asset to our team. His experience will help us take our partnerships with Pharma, care providers, payers and researchers to the next level. What makes Claudio so unique is in-depth understanding of the global oncology field from both a commercial and a scientific perspective. His appointment is central to our growth strategy in the US”, says Jani Ahonala, CEO of Noona.


Claudio D´Ambrosio, PhD
Chief Commercial Officer, US
(+44) 77 69506807

May 29th 2020

We hire for purpose 1

We hire for purpose

Many employers say they have a great cause, offer meaningful work and talk about their purpose. We continuously bring together the world’s best talent to work for our mission of saving lives.


Read more

May 29th 2020

Varian in Finland

Varian in Finland

Varian is a well-established oncology software company in Finland.

Our employees at Varian Finland are using their extensive skills in programming, data science, applied mathematics, and physics to...

Read more

March 19th 2020

What does Varian do exactly

You asked, we answer – What does Varian do exactly?

Like all employers, we often get asked what does Varian do exactly?

Our Noona-team is now part of Varian, and at Varian, we envision a world without fear of cancer. This is a huge vision, and we tr...

Read more

March 05th 2020

Pasi Heiskanen Noonateam Meaning of work working at Noona-team

Co-founders’ story – My three reasons for working at Noona

I often get asked what fascinates me about developing oncology care solutions for patients. Founding and scaling a business never comes easy. It is helpful t...

Read more

July 03rd 2019

Varian to Provide Mobile Technology to Cancer Patients Across Tennessee

PALO ALTO, Calif., June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased participation in their treatment, Varian (NYSE: VAR) today announced its collaboration with Tenn...

Read more

February 15th 2019

Varian Demonstrating Smarter Cancer Care Solutions at HIMSS19

PALO ALTO, Calif., Feb. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMS...

Read more